Picture of Sapporo Clinical Laboratory logo

9776 — Sapporo Clinical Laboratory News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMicro CapSuper Stock

Table: Sapporo Clinical Lab - 6-MTH group results

Nov 10 (Reuters)-  
             Sapporo Clinical Laboratory Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2017        Sep 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             8.72                8.43             17.70     
                 (+3.4 pct)          (-1.9 pct)       (+3.8 pct)   
  Operating        509 mln             350 mln          751 mln    
                 (+45.5 pct)         (-30.1 pct)      (-2.6 pct)   
  Recurring        522 mln             370 mln          778 mln    
                 (+41.0 pct)         (-27.6 pct)      (-3.1 pct)   
  Net              346 mln             239 mln          522 mln    
                 (+44.7 pct)         (-25.2 pct)      (+1.8 pct)   
  EPS             99.62 yen           68.84 yen       150.28 yen   
  Ann Div                             10.00 yen        10.00 yen   
  -Q2 div            NIL                 NIL                       
  -Q4 div                             10.00 yen        10.00 yen   
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Sapporo Clinical Laboratory

See all news